Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis

Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression...

Descripción completa

Detalles Bibliográficos
Autores principales: Jwa, Hye Young, Cho, Yoo-Kyung, Choi, Eun Kwang, Kim, Heung Up, Song, Hyun Joo, Na, Soo-Young, Boo, Sun-Jin, Jeong, Seung Uk, Kim, Bong Soo, Lee, Byoung-Wook, Song, Byung-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825159/
https://www.ncbi.nlm.nih.gov/pubmed/27044771
http://dx.doi.org/10.3350/cmh.2016.22.1.183
Descripción
Sumario:Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis, suggesting that complications of liver cirrhosis such as esophageal varices can regress after the long-term suppression of HBV replication.

Ejemplares similares